Publications by authors named "Robert Ryall"

Claim this Profile
P
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
Elisa Nemes, Hennie Geldenhuys, Virginie Rozot, Kathryn T Rutkowski, Frances Ratangee, Robert Ryall

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
Marie-Clotilde Bernard, Véronique Barban, Fabrine Pradezynski, Aymeric de Montfort, Robert Ryall

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial.
Hennie Geldenhuys, Helen Mearns, David J C Miles, Michele Tameris, David Hokey, Robert Ryall

Vaccine· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a meningococcal (Groups A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine in healthy children aged 2 to 10 years in Chile.
Rosanna Lagos, Thomas Papa, Alma Muñoz, Robert Ryall, Miriam Pina

Hum Vaccin· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.
Harry Keyserling, Thomas Papa, Katalin Koranyi, Robert Ryall, Ehab Bassily

Arch Pediatr Adolesc Med· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.
Michael Pichichero, Janet Casey, Mark Blatter, Edward Rothstein, Robert Ryall

Pediatr Infect Dis J· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of residual EDU (N-ethyl-N'-(dimethylaminopropyl) carbodiimide (EDC) hydrolyzed urea derivative) and other residual by LC-MS/MS.
Q Paula Lei, David H Lamb, Anthony G Shannon, Xinxing Cai, Ronald K Heller, Robert Ryall

J Chromatogr B Analyt Technol Biomed Life Sci· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LC/MS characterization of meningococcal depolymerized polysaccharide group C reducing endgroup and internal repeating unit.
Xinxing Cai, Q Paula Lei, David H Lamb, Anthony Shannon, Jason Jacoby, Robert Ryall

Anal Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
Margaret Rennels, James King, Robert Ryall, Thomas Papa, James Froeschle

Pediatr Infect Dis J· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
Helen Joseph, Paul Balmer, Mike Bybel, Thomas Papa, Robert Ryall

Clin Diagn Lab Immunol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children.
Helen Joseph, Robert Ryall, Mike Bybel, Thomas Papa, Jenny MacLennan

J Infect Dis· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.
James D Campbell, Robert Edelman, James C King, Thomas Papa, Robert Ryall

J Infect Dis· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic studies on the rate of hydrolysis of N-ethyl-N'-(dimethylaminopropyl)carbodiimide in aqueous solutions using mass spectrometry and capillary electrophoresis.
Q Paula Lei, David H Lamb, Ron K Heller, Anthony G Shannon, Robert Ryall

Anal Biochem· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers.
Margaret Rennels, James King, Robert Ryall, Susan Manoff, Thomas Papa

Pediatr Infect Dis J· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis